{"schema_version":"secwatch.filing_event.v1","accession":"0001367644-24-000134","form_type":"8-K","ticker":"EBS","cik":"0001367644","company_name":"Emergent BioSolutions Inc.","filed_at":"2024-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.798125+00:00","generated_at":"2026-05-31T14:18:47.496284+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Emergent BioSolutions sells RSDL decontamination kit to SERB for $75M","bullets":["Cash purchase price of $75M at closing; additional $5M milestone payment for component sourcing.","Sale includes Hattiesburg, MS manufacturing facility, IP, inventory, and marketing authorizations; employees to join SERB.","Emergent's Winnipeg facility will manufacture bulk lotion for SERB under long-term supply agreement.","SERB assumes existing RSDL supply contract with U.S. Department of Defense.","Net proceeds expected to reduce debt by >$150M, targeting elimination of Junior Capital Raise requirement."],"urls":{"canonical":"https://secwatch.observer/filing/0001367644-24-000134","json":"https://secwatch.observer/filing/0001367644-24-000134.json","markdown":"https://secwatch.observer/filing/0001367644-24-000134.md","text":"https://secwatch.observer/filing/0001367644-24-000134.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367644/000136764424000134/0001367644-24-000134-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367644/000136764424000134/ebs-20240731.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T14:18:47.496284+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}